AOD-9604: the fat metabolism modulator

What Is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone (HGH), specifically the C-terminal end (amino acids 176-191), which is believed to be responsible for fat-burning activity—without the growth-related effects of full-length HGH.

Unlike HGH, AOD-9604 is not classified as an anabolic agent, and has been explored primarily for its potential role in modulating lipolysis (fat breakdown) and preventing lipogenesis (fat accumulation).

What the Research Indicates

Studies—primarily in animal models and small human trials—have explored the following possible effects of AOD-9604:

• Enhanced fat metabolism, particularly in abdominal and visceral regions

• No impact on insulin sensitivity or blood sugar levels

• No effect on IGF-1 levels, making it distinct from HGH

• Potential support in cartilage and joint health (observed in some models)

While early research shows promise, it's worth noting that clinical data in large-scale human studies remains limited. Its use is often off-label and under medical supervision.

Delivery and Regulation

AOD-9604 is typically administered via subcutaneous injection. It is not approved by the FDA for fat loss but is often available in wellness and longevity clinics as a research compound or part of off-label optimization programs.

As always, any use should be discussed with a licensed healthcare provider.

Curious About AOD-9604?

If you're exploring options for supporting body composition or metabolic health, InnerFlux offers educational insight only—no prescriptions or sales. To be connected with a licensed provider familiar with peptides like AOD-9604, just head to the contact form.